Nicholas Investment Partners, LP Karuna Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$161.01 - $317.85 $13.3 Million - $26.2 Million	-82,457 Reduced 89.53%	9,644 $3.05 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $10.5 Million - $13.9 Million	-63,829 Reduced 40.93%	92,101 $15.6 Million
Q2 2023 Aug 09, 2023	BUY	$176.32 - $240.22 $19,042 - $25,943	108 Added 0.07%	155,930 $33.8 Million
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $9.47 Million - $12 Million	58,694 Added 60.43%	155,822 $28.3 Million
Q4 2022 Feb 10, 2023	BUY	$191.53 - $236.82 $3.81 Million - $4.71 Million	19,874 Added 25.73%	97,128 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $2.66 Million - $5.96 Million	21,493 Added 38.54%	77,254 $17.4 Million
Q2 2022 Aug 10, 2022	BUY	$93.97 - $143.33 $3.34 Million - $5.1 Million	35,572 Added 176.19%	55,761 $7.05 Million
Q1 2022 May 10, 2022	BUY	$98.9 - $132.37 $2 Million - $2.67 Million	20,189 New	20,189 $2.56 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.